Skip to main content

UNC Lineberger patient Morgan Throckmorton was diagnosed with colon cancer in 2009 when she was 24 years old. She is now part of a UNC-led trial to test a new drug, Regorafinib.

She talks about her diagnosis and treatment and why she wanted to take part in the clinical trial.

Dr. Bert O’Neil, a faculty member in UNC Lineberger’s Gastrointestinal Oncology program, talks about the K-RAS mutation – which Throckmorton tested positive for – which is present in about a third of colon cancer cases.

Read more and watch video.